The UK pharmaceutical services company. Clinigen Group PLCis planning to acquire Quantum Pharma PLC in a cash-and-share deal valued at £150.3m ($199.5m), enlarging Clinigen's activities in the ethical supply of unlicensed medicines in the UK and continental Europe, and strengthening its role in commercializing medicine.
The interest of Clinigen in Quantum became public in the middle of last month, and the two AIM-listed companies have...








